Table 3.
Prevalence of depression using MINI among different cancer types, stage, and different treatment
| Types of cancer | Total (N) | MDE (N) | Percent (%) MDE |
|---|---|---|---|
| Breast | 47 | 6 | 13% |
| Skin | 26 | 4 | 15% |
| Gastrointestinal | 22 | 2 | 9% |
| Cervical | 20 | 5 | 25% |
| Oropharyngeal | 15 | 2 | 13% |
| Prostate | 9 | 1 | 11% |
| Others | 24 | 5 | 21% |
| Total | 163 | 25 | 15.3% |
| Cancer stage | |||
| Stage I | 26 | 3 | 11.5% |
| Stage II | 78 | 15 | 19% |
| Stage III | 40 | 3 | 7.5% |
| Stage IV | 2 | 1 | 50% |
| Total | 146 | 22 | 15.3% |
| Treatment | |||
| Chemotherapy only | 77 | 7 | 9% |
| Radiotherapy only | 33 | 8 | 24% |
| Chemo & radiotherapy only | 48 | 7 | 14.6% |
| Chemotherapy & surgery only | 2 | 0 | 0% |
| Radiotherapy & surgery | 1 | 1 | 100% |
| No treatment | 2 | 2 | 100% |
| Total | 163 | 25 | 15.3% |